{
    "Trade/Device Name(s)": [
        "AllTest Multi-Drug Urine Test Panel",
        "AllTest Multi-Drug Rapid Urine Test Panel"
    ],
    "Submitter Information": "Hangzhou AllTest Biotech Co., Ltd.",
    "510(k) Number": "K242540",
    "Predicate Device Reference 510(k) Number(s)": [
        "K241428"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "August 23, 2024",
    "Summary Letter Received Date": "August 26, 2024",
    "Submission Date": "August 23, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "Unclassified",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocainemetabolite test system",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Buprenorphine (BUP)",
        "Secobarbital (BAR)",
        "Oxazepam (BZO)",
        "Cocaine (COC)",
        "Methamphetamine (MET)",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine (MOP/OPI)",
        "Methadone (MTD)",
        "Oxycodone (OXY)",
        "Phencyclidine (PCP)",
        "Nortriptyline (TCA)",
        "Marijuana (THC)",
        "Fentanyl (FYL)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Immunochromatographic",
        "Competitive binding",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for AllTest Multi-Drug Urine Test Panel and Rapid Panel for simultaneous qualitative detection of multiple drugs of abuse in human urine using lateral flow immunochromatography",
    "Indications for Use Summary": "Intended for the qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline, Marijuana, and Fentanyl in human urine for OTC and in vitro diagnostic use; preliminary results only, confirmation by alternate chemical method recommended.",
    "fda_folder": "Toxicology"
}